NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 31 filers reported holding NOVOCURE LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,003,780 | +0.9% | 34,882 | +1.9% | 0.01% | -16.7% |
| Q1 2023 | $2,977,574 | -4.0% | 34,244 | -1.9% | 0.01% | -14.3% |
| Q4 2022 | $3,100,727 | +3.5% | 34,890 | +4.2% | 0.01% | -6.7% |
| Q3 2022 | $2,995,000 | -19.9% | 33,489 | -20.9% | 0.02% | -11.8% |
| Q2 2022 | $3,740,000 | +14.3% | 42,358 | +18.6% | 0.02% | +30.8% |
| Q1 2022 | $3,271,000 | -2.2% | 35,700 | 0.0% | 0.01% | +8.3% |
| Q4 2021 | $3,345,000 | – | 35,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 46,391,000 | $42,604,000 | 1.32% |
| Lombard Odier Asset Management (Europe) Ltd | 171,980 | $15,871,000 | 0.70% |
| WOLVERINE ASSET MANAGEMENT LLC | 80,367,000 | $73,232,000 | 0.68% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,419,000 | $5,736,000 | 0.39% |
| LINDEN ADVISORS LP | 63,485,000 | $58,560,000 | 0.36% |
| Ionic Capital Management LLC | 3,000,000 | $2,771,000 | 0.35% |
| SSI INVESTMENT MANAGEMENT LLC | 5,859,000 | $5,354,000 | 0.31% |
| Verition Fund Management LLC | 33,485,000 | $30,766,000 | 0.22% |
| Nicholas Investment Partners, LP | 3,550,000 | $3,244,000 | 0.20% |
| TFG Asset Management GP Ltd | 3,000,000 | $2,769,000 | 0.17% |